8-KThe WireRoutine
Reg FD Disclosure
Filed Dec 17, 2021 · 4y ago · Accession 0001193125-21-359961
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Kalaris Therapeutics, Inc.
- Ticker
- KLRS
- CIK
- 1754068
- Form type
- 8-K
- Filing date
- Dec 17, 2021
- Report date
- Dec 16, 2021
- Document
- d256659d8k.htm
- Size
- 162 KB